Technique has potential to help reverse the most common type of disease-associated mutations

Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance

Agreement supports collaborative advancement of research in a range of therapeutic areas by researchers from across Harvard

Innovations in fluid injection, sequencing polynucleotides, isolation of white blood cells, DNA origami devices, film deposition, and more